1887

Abstract

We have characterized the mechanism for human immunodeficiency virus type 1 (HIV-1) latent infection in a human T cell line MOLT-4 subclone no. 8 (MOLT-#8). The inocula used were HIV-1 recovered from MT-4 during the acute (NL-A) and persistent (NL-P) phases after HIV-1 infection. On infection of MOLT-#8 with NL-A, viral antigens first appeared in almost 100% of the cells whereafter the numbers of viable antigen-positive cells declined. In contrast, following infection with NL-P the expression of viral antigens was maintained in almost 100% of the cells. In fact, limiting dilution of NL-P-infected cells allowed us to isolate 43 subclones, all of which were positive for viral antigen expression in almost 100% of the cells (type I). In sharp contrast, only two of 41 subclones from NL-A-infected cells were of type I. Seven subclones were latently infected with HIV-1; latent HIV-1 in six subclones (type II), but not in one type III subclone, was activated by tumour necrosis factor (TNF)- or phorbol 12-myristate 13-acetate. The remaining subclones were negative for the viral genome. Of particular note is the effect of endogenous TNF- generated during the acute phase of virus replication which shifted the virus phenotype. Thus, the presence of TNF- during the acute phase of virus replication seems to play a key role in the selective destruction of cells expressing higher levels of viral antigens and in subsequent establishment of latent infection in host T cells.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-79-2-221
1998-02-01
2024-03-28
Loading full text...

Full text loading...

/deliver/fulltext/jgv/79/2/9472606.html?itemId=/content/journal/jgv/10.1099/0022-1317-79-2-221&mimeType=html&fmt=ahah

References

  1. Adachi A., Gendelman H. E., Koenig S., Folks T., Willey R., Robson A., Martin M. A. 1986; Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone. Journal of Virology 59:284–291
    [Google Scholar]
  2. Cao Y., Ho D. D., Todd J., Kokka R., Urdea M., Lifson J. D., Piatak M.Jr Chen S., Hahn B. H., Saag M. S., Shaw G. M. 1995; Clinical evaluation of branched DNA signal amplification for quantifying HIV type 1 in human plasma. AIDS Research and Human Retroviruses 11:353–361
    [Google Scholar]
  3. Duh E. J., Maury W. J., Folks T. M., Fauci A. S., Rabson A. B. 1989; Tumor necrosis factor a activates human immunodeficiency virus type 1 through induction of nuclear factor binding to the NF-KB sites in the long terminal repeat. Proceedings of the National Academy of Sciences, USA 86:5974–5978
    [Google Scholar]
  4. Embretson J., Zupancic M., Ribas J. L., Burke A., Racz P., Tenner-Racz K., Haase A. T. 1993a; Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS. Nature 362:359–362
    [Google Scholar]
  5. Embretson J., Zupancic M., Beneke J., Till M., Wolinsky S., Ribas J. L., Burke A., Haase A. T. 1993b; Analysis of human immunodeficiency virus-infected tissues by amplification of in situ hybridization reveals latent and permissive infections at single-cell resolution. Proceedings of the National Academy of Sciences, USA 90:357–361
    [Google Scholar]
  6. Fujinaga K., Zhong Q., Nakaya T., Kameoka M., Meguro T., Yamada K., Ikuta K. 1995; Extracellular Nef protein regulates productive HIV-1 infection from latency. Journal of Immunology 155:5289–5298
    [Google Scholar]
  7. Fujinaga K., Nakamura Y., Zhong Q., Nakaya T., Ikuta K. 1996; Growth dominance of a revertant virus generated during in vitro serial passage of nef frameshift mutant of HIV-1. Biochemical and Biophysical Research Communications 229:96–101
    [Google Scholar]
  8. Herbein G., Montaner L. J., Gordon S. 1996; Tumor necrosis factor alpha inhibits entry of human immunodeficiency virus type 1 into primary human macrophages: a selective role for the 75-kilodalton receptor. Journal of Virology 70:7388–7397
    [Google Scholar]
  9. Ho D. D., Neumann A. U., Perelson A. S., Chen W., Leonard J. M., Markowitz M. 1995; Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 373:123–126
    [Google Scholar]
  10. Kikukawa R., Koyanagi Y., Harada S., Kobayashi N., Hatanaka M., Yamamoto N. 1986; Differential susceptibility to the acquired immunodeficiency syndrome retrovirus in cloned cells of human leukemic T-cell line Molt-4. Journal of Virology 57:1159–1162
    [Google Scholar]
  11. Kishi M., Nishino Y., Sumiya M., Ohki K., Kimura T., Goto T., Nakai M., Kakinuma M., Ikuta K. 1992; Cells surviving infection by human immunodeficiency virus type 1: vif or vpu mutants produce noninfectious or markedly less cytopathic viruses. Journal of General Virology 73:77–87
    [Google Scholar]
  12. Kishi M., Zheng Y.-H., Bahmani M. K., Tokunaga K., Takahashi H., Kakinuma M., Lai P. K., Nonoyama M., Luftig R. B., Ikuta K. 1995; Naturally occurring accessory gene mutations lead to persistent human immunodeficiency virus type 1 infection of CD4-positive T cells. Journal of Virology 69:7507–7518
    [Google Scholar]
  13. Koup R. A., Safrit J. T., Cao Y., Andrews C. A., McLeod G., Borkowsky W., Farthing C., Ho D. D. 1994; Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome. Journal of Virology 68:4650–4655
    [Google Scholar]
  14. Levy J. A. 1993; Pathogenesis of human immunodeficiency virus infection. Microbiology Reviews 57:183–289
    [Google Scholar]
  15. Levy D. N., Refaeli Y., MacGregor R. R., Weiner D. B. 1994; Serum Vpr regulates productive infection and latency of human immunodeficiency virus type 1. Proceedings of the National Academy of Sciences, USA 91:10873–10877
    [Google Scholar]
  16. Levy D. N., Refaeli Y., Weiner D. B. 1995; Extracellular Vpr protein increases cellular permissiveness to human immunodeficiency virus replication and reactivates virus from latency. Journal of Virology 69:1243–1252
    [Google Scholar]
  17. Matsuyama T., Hamamoto Y., Soma G., Mizuno D., Yamamoto N., Kobayashi N. 1989; Cytocidal effect of tumor necrosis factor on cells chronically infected with human immunodeficiency virus (HIV): en-hancement of HIV replication. Journal of Virology 63:2504–2509
    [Google Scholar]
  18. Michael N. L., Mo T., Merzouki A., O’Shaughnessy M., Oster C., Burke D. S., Redfield R. R., Birx D. L., Cassol S. A. 1995; Human immunodeficiency virus type 1 cellular RNA load and splicing patterns predict disease progression in a longitudinally studied cohort. Journal of Virology 69:1868–1877
    [Google Scholar]
  19. Minowada J., Ohnuma T., Moore D. E. 1972; Rosette forming human lymphoid cell lines. I. Establishment and evidence for origin of thymus-derived lymphocytes. Journal of the National Cancer Institute 49:891–895
    [Google Scholar]
  20. Miyoshi I., Taguchi H., Kubonishi I., Yoshimoto S., Ohtsuki Y., Shiraishi Y., Akagi T. 1982; Type C virus producing cell lines derived from adult T cell leukemia. In Adult T Cell Leukemia and Related Diseases, GANN Monograph on Cancer Research28 pp. 219–228 Hanaoka M., Takatsuki K., Shimoyama M. Edited by Tokyo: Japan Scientific Societies Press;
    [Google Scholar]
  21. Nakaya T., Fujinaga K., Kishi M., Oka S., Kurata T., Jones I. M., Ikuta K. 1994; Nonsense mutations in the vpr gene of HIV-1 during in vitro virus passage and in HIV-1 carrier-derived peripheral blood mononuclear cells. FEBS Letters 354:17–22
    [Google Scholar]
  22. Nakaya T., Fujinaga K., Doi H., Suzuki S., Takahashi H., Nishino Y., Kishi M., Azuma I., Luftig R. B., Ikuta K. 1996; Serial passage of human immunodeficiency virus type 1, generates misalignment deletions in non-essential accessory genes. Virus Research 46:139–147
    [Google Scholar]
  23. Nishino Y., Kishi M., Sumiya M., Ogawa K., Adachi A., Maotani-Imai K., Kato S., Hirai K., Ikuta K. 1991; Human immunodeficiency virus type 1 vif, vpr, and vpu mutations can produce persistently infected cells. Archives of Virology 120:181–192
    [Google Scholar]
  24. Nishino Y., Nakaya T., Fujinaga K., Kishi M., Azuma I., Ikuta K. 1994; Persistent infection of MT-4 cells by human immunodeficiency virus type 1 becomes increasingly likely with in vitro serial passage of wild type but not nef mutant virus. Journal of General Virology 75:2241–2251
    [Google Scholar]
  25. Osborn L., Kunkel S., Nabel G. J. 1989; Tumor necrosis factor a and interleukin 1 stimulate the human immunodeficiency virus enhancer by activation of the nuclear factor kB. Proceedings of the National Academy of Sciences, USA 86:2336–2340
    [Google Scholar]
  26. Panteleo G., Graziosi C., Demarest J. F., Butini L., Montroni M., Fox C., Orenstein J. M., Kotler D. P., Fauci A. S. 1993; HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease. Nature 362:355–358
    [Google Scholar]
  27. Panteleo G., Demarest J. F., Soudeyns H., Adelsberger J. W., Borrow P., Saag M. S., Shaw G. M., Sekaly R. P., Fauci A. 1994; Major expansion of CD8+ T cells with a predominant Vβ usage during the primary immune response to HIV. Nature 370:463–467
    [Google Scholar]
  28. Patterson B. K., Till M., Otto P., Goolsby C., Furtado M. R., McBride L. J., Wolinsky S. M. 1993; Detection of HIV-1 DNA and messenger RNA in individual cells by PCR-driven in situ hybridization and flow cytometry. Science 260:976–979
    [Google Scholar]
  29. Perelson A. S., Neumann A. U., Markowitz M., Leonard J. M., Ho D. D. 1996; HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time. Science 271:1582–1586
    [Google Scholar]
  30. Poli G., Fauci A. S. 1992; The effect of cytokines and pharmacologic agents on chronic HIV infection. AIDS Research and Human Retroviruses 8:191–197
    [Google Scholar]
  31. Rosenberg Z. F., Fauci A. S. 1990; Immunopathogenic mechanisms of HIV infection: cytokine induction of HIV expression. Immunology Today 11:176–180
    [Google Scholar]
  32. Wei X., Ghosh S. K., Taylor M. E., Johnson V. A., Emini E. A., Deutsch P., Lifson J. D., Bonhoeffer S., Nowak M. A., Hahn B. H., Saag M. S., Shaw G. M. 1995; Viral dynamics in human immunodeficiency virus type 1 infection. Nature 373:117–122
    [Google Scholar]
  33. Yunoki M., Maotani-Imai K., Kusuda H., Motoyama M., Miyake S., Imai H., Shin Y. S., Kato S., Sano K., Morita C., Nakai M., Hirai K., Ikuta K. 1991; Production of infectious particles from defective human immunodeficiency virus type 1 (HIV-1)-producing cell clones by superinfection with infectious HIV-1. Archives of Virology 116:143–158
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-79-2-221
Loading
/content/journal/jgv/10.1099/0022-1317-79-2-221
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error